| |
| | CancerNetwork.com:Cancer Screening, Diagnosis, and Treatment (Site not responding. Last check: 2007-10-18) |
 | | The encapsulation of chemotherapeutic agents, including doxorubicin, in liposomes has shown in animal and human models to reduce certain toxic effects. |
 | | A roundtable discussion was convened on November 22, 1996, in Tucson, Arizona, to gather existing and evolving data on the use of single-agent pegylated liposomal doxorubicin (Doxil) in the treatment of cancer and to describe its current status and its future applications in the delivery of cancer chemotherapy. |
 | | Also, the favorable pharmacokinetic parameters of the encapsulated formulationslonger half-life, greater area under the concentration-time curve (AUC), and slower clearancemay allow the lesions to be exposed to these cytotoxic agents for longer periods of time. |
| www.cancernetwork.com /contents/o9710supp11.htm (1649 words) |
|